Mohammad S. Afana

Doha, DA, Qatar

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Dose Optimization of Dasatinib in Chronic-Phase Chronic Myeloid Leukemia: A Systematic Review and Meta-analysis of 50 mg Versus 100 mg Once Daily.

Dose Optimization of Dasatinib in Chronic-Phase Chronic Myeloid Leukemia: A Systematic Review and Meta-analysis of 50 mg Versus 100 mg Once Daily.

Journal: Clinical lymphoma, myeloma & leukemia

Published: June 12, 2026

Venetoclax-Based Regimens in Chronic Myelomonocytic Leukemia: A Systematic Review and Meta-Analysis.

Venetoclax-Based Regimens in Chronic Myelomonocytic Leukemia: A Systematic Review and Meta-Analysis.

Journal: Acta haematologica

Published: January 21, 2026

Venetoclax-Based Regimens in Chronic Myelomonocytic Leukemia: A Systematic Review and Meta-Analysis.

Venetoclax-Based Regimens in Chronic Myelomonocytic Leukemia: A Systematic Review and Meta-Analysis.

Journal: Acta haematologica

Published: January 21, 2026

Isolated del(5q) with myeloproliferative driver mutations: A systematic review of published cases and clinical implications.

Isolated del(5q) with myeloproliferative driver mutations: A systematic review of published cases and clinical implications.

Journal: Therapeutic advances in hematology

Published: August 20, 2025

Potential efficacy of crizanlizumab in treating priapism in sickle cell disease: A case report.

Potential efficacy of crizanlizumab in treating priapism in sickle cell disease: A case report.

Journal: Clinical case reports

Published: January 22, 2024

Obstructive Sleep Apnea Does Not Exclude Polycythemia Vera: A Case Report.

Obstructive Sleep Apnea Does Not Exclude Polycythemia Vera: A Case Report.

Journal: Case reports in oncology

Published: October 01, 2023

Recurrence of acute chest syndrome post stopping Crizanlizumab, the dilemma of stopping vs continuation in patient with sickle cell disease: case report.

Recurrence of acute chest syndrome post stopping Crizanlizumab, the dilemma of stopping vs continuation in patient with sickle cell disease: case report.

Journal: Hematology (Amsterdam, Netherlands)

Published: July 31, 2023

Toe Gangrene as the First Presenting Symptom of Essential Thrombocythemia: A Case Report.

Toe Gangrene as the First Presenting Symptom of Essential Thrombocythemia: A Case Report.

Journal: Cureus

Published: July 24, 2023

Radioactive Iodine-Induced Chronic Myeloid Leukemia in a Patient With Graves' Disease: A Case Report.

Radioactive Iodine-Induced Chronic Myeloid Leukemia in a Patient With Graves' Disease: A Case Report.

Journal: Cureus

Published: February 22, 2023

A Challenging Case of a Patient With Immune Thrombocytopenic Purpura on Eltrombopag Who Developed Atrial Fibrillation: An Anticoagulation Dilemma.

A Challenging Case of a Patient With Immune Thrombocytopenic Purpura on Eltrombopag Who Developed Atrial Fibrillation: An Anticoagulation Dilemma.

Journal: Cureus

Published: February 14, 2023

Myocardial Infarction as an Initial Presentation of Essential Thrombocythemia With Calreticulin (CALR) Mutation (None Type 1, None Type 2).

Myocardial Infarction as an Initial Presentation of Essential Thrombocythemia With Calreticulin (CALR) Mutation (None Type 1, None Type 2).

Journal: Cureus

Published: January 02, 2023

Applications of Artificial Intelligence in Philadelphia-Negative Myeloproliferative Neoplasms.

Applications of Artificial Intelligence in Philadelphia-Negative Myeloproliferative Neoplasms.

Journal: Diagnostics (Basel, Switzerland)

Published: December 25, 2022

Showing 1-12 of 13

Last Updated: 09/26/2026